334 The importance of prognostic parametres for the allogeneic transplantation course in patients with myelodysplastic syndromes and secondary acute leukemia von Vondráková, J, Bělohlávková, P, Zapletalová, J, Raida, L, Žák, P, Jebavý, L, Voglová, J, Zavřelová, A, Lánská, M, Pikalová, Z, Skoumalová, I, Jarošová, M, Faber, E, Malý, J, Indrák, K

Volltext

Oral Compliacation after Bone Marrow Transplantation von Pink, R., Kadlec, Z., Pazdera, J., Michl, P., Tvrdý, P., Zbořil, V., Rajda, L., Vondráková, J., Faber, E., Indrák, K.

Volltext

P.086 Salivary neutrophils – indicator of a bone marrow engraftment von Pink, R, Vondráková, J, Faber, E, Skoumalová, I, Marešová, I, Koupilová, M, Pazdera, J, Indrák, K

Volltext

211 Deferasirox vs. deferiprone treatment in iron overloaded patients with myelodysplastic syndrome – a study on 113 patients with low-risk MDS von Cermak, J, Jonasova, A, Vondrakova, J, Cervinek, L, Belohlavkova, P, Sponerova, D, Novakova, L, Walterova, L, Neuwirtova, R

Volltext

175 Czech MDS Group experience with azacitidine in treatment of high risk MDS and AML patients von Jonasova, A, Cermak, J, Cervinek, L, Novakova, L, Vondrakova, J, Belohlavkova, P, Sykora, M, Seifertova, N, Walterova, L, Libiger, J, Michalova, K, Zemanova, Z, Brezinova, J, Kacmarova, K, Klapka, R

Volltext

124 Are we warranted to include patients with del 5q and trisomy 8 into the 5q minus syndrome? von Neuwirtova, R, Vozobulova, V, Jonasova, A, Voglova, J, Vondrakova, J, Cermak, J, Sponerova, D, Novakova, L, Stejskal, L, Zmolikova, J, Maskova, Z, Klimova, O, Kessler, P, Cervinek, L, Seifertova, N, Zemanova, Z

Volltext

301 Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and Intermediate-1) von Jonasova, A, Cermak, J, Vondrakova, J, Siskova, M, Hochova, I, Kadlckova, E, Cerna, O, Sykora, M, Vozobulova, V, Seifertova, N, Michalova, K, Zemanova, Z, Brezinova, J, Belohlavkova, P, Neuwirtova, R

Volltext

P075 Characteristics of patients with therapy-related myelodysplastic syndrome von Belohlavkova, P, Voglova, J, Neuwirtova, R, Krejcova, H, Cermak, J, Vondrakova, J, Vozobulova, V, Krejci, M, Muzik, J

Volltext

250 Are Fli1, EKLF, PU.1, HDM2 and TP53 factors implicated in refractory anemia and megakaryopoiesis in 5q- syndrome? von Neuwirtova, R, Fuchs, O, Jonasova, A, Holicka, M, Vostry, M, Kostecka, A, Hajkova, H, Cermak, J, Vondrakova, J, Hochova, I, Siskova, M, Libiger, J, Sponerova, D, Kadlckova, E, Novakova, L, Cerna, O, Cmejla, R, Pospisilova, D, Brezinova, J, Zemanova, Z, Michalova, K, Seifertova, N

Volltext

195 Cytochrome P450 2E1 is present and active in human hematopoietic stem cells von Anzenbacher, P., Anzenbacherova, E., Kousalová, L., Vondráková, J., Skoumalová, I.

Volltext

P081 The questions on megakaryopoiesis in MDS patients with del(5q) von Neuwirtova, R, Jonasova, A, Cermak, J, Vondrakova, J, Hochova, I, Jungova, A, Belohlavkova, P, Siskova, M, Kadlckova, E, Cerna, O, Smolikova, A, Polonyova, E, Bruchova, H, Zemanova, Z, Mikulenkova, D

Volltext

Oral Mucositis as a Side Effect of Myeloablative Chemotherapy in Hemato-oncological Patients von R. Pink, J. Pazdera, J. Vondráková, E. Faber, I. Skoumalová

Volltext

P201 High-dose therapy and autologous transplantation in poor prognosis patients with diffuse large B-cell lymphoma in first remission von Papajik, T, Raida, L, Faber, E, Prochazka, V, Vondrakova, J, Skoumalova, I, Kubova, Z, Jarosova, M, Jarkovský, J, Dusek, L, Indrak, K

Volltext

Comparison of Conditioning Regimens BU-CY and FLU-BU12-TG Used in the Patients Undergoing Allogeneic Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML) von Raida, L, Tucek, P, Vondrakova, J, Rusinakova, Z, Faber, E, Indrak, K

Volltext

Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia – the Retrospective Analysis von Vondrakova, J, Belohlavkova, P, Zapletalova, J, Raida, L, Zak, P, Jebavy, L, Voglova, J, Zavrelova, A, Pikalova, Z, Skoumalova, I, Jarosova, M, Faber, E, Maly, J, Indrak, K

Volltext

187: Fludarabin and Cyclophosphamide Based Non-Myeloablative Conditioning Regimens in the Patients Allografted for Recurrent/Refractory Malignant Lymphoproliferative Disorders von Raida, L, Vondrakova, J, Faber, E, Papajik, T, Indrak, K, Langova, K

Volltext

MAIA, Fc receptor–like 3, supersedes JUNO as IZUMO1 receptor during human fertilization von Vondrakova, J, Frolikova, M, Ded, L, Cerny, J, Postlerova, P, Palenikova, V, Simonik, O, Nahacka, Z, Basus, K, Valaskova, E, Machan, R, Pacey, A, Holubcova, Z, Koubek, P, Ezrova, Z, Park, S, Liu, R, Partha, R, Clark, N, Neuzil, J, Ikawa, M, Erickson, K, Lam, K.S, Moore, H, Komrskova, K

Volltext bestellen

Prognostic factors for survival of patients with non-hodgkin’s lymphoma (NHL) after autologous peripheral stem cell transplantation (APSCT)—single center experience von Faber, E., Vondrakova, J., Zapletalova, J., Skoumalova, I., Maresova, I., Raida, L., Papajik, T., Indrak, K.

Volltext

Myeloablative chemotherapy and autologous stem cell transplantation in poor prognosis patients with advanced follicular lymphoma—effective therapy in first complete or partial remi... von Papajik, T., Faber, E., Raida, L., Prochazka, V., Vondrakova, J., Rozmanova, S., Jarosova, M., Indrak, K.

Volltext

The FLOWERING LOCUS T LIKE 2-1 gene of Chenopodium triggers precocious flowering in Arabidopsis seedlings von Abeyawardana, Oushadee A. J., Moravec, Tomáš, Krüger, Manuela, Belz, Claudia, Gutierrez-Larruscain, David, Vondráková, Zuzana, Eliášová, Kateřina, Štorchová, Helena

Volltext